Strata Skin Sciences, Inc.
SSKN
$2.59
-$0.03-1.15%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 9.58M | 8.80M | 8.44M | 6.75M | 8.69M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.58M | 8.80M | 8.44M | 6.75M | 8.69M |
| Cost of Revenue | 3.82M | 3.49M | 3.50M | 3.67M | 3.89M |
| Gross Profit | 5.76M | 5.31M | 4.94M | 3.08M | 4.80M |
| SG&A Expenses | 5.92M | 6.72M | 5.22M | 5.73M | 5.58M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.94M | 10.45M | 8.92M | 9.64M | 9.85M |
| Operating Income | -366.00K | -1.65M | -486.00K | -2.89M | -1.16M |
| Income Before Tax | -4.67M | -2.12M | -99.00K | -3.37M | -3.89M |
| Income Tax Expenses | -170.00K | -- | -- | -- | -92.00K |
| Earnings from Continuing Operations | -4.50M | -2.12M | -99.00K | -3.37M | -3.79M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.50M | -2.12M | -99.00K | -3.37M | -3.79M |
| EBIT | -366.00K | -1.65M | -486.00K | -2.89M | -1.16M |
| EBITDA | 864.00K | -414.00K | 764.00K | -1.64M | 122.00K |
| EPS Basic | -1.08 | -0.53 | -0.03 | -0.96 | -1.08 |
| Normalized Basic EPS | -0.12 | -0.33 | -0.17 | -0.60 | -0.29 |
| EPS Diluted | -1.08 | -0.53 | -0.03 | -0.96 | -1.08 |
| Normalized Diluted EPS | -0.12 | -0.33 | -0.17 | -0.60 | -0.29 |
| Average Basic Shares Outstanding | 4.17M | 4.04M | 3.51M | 3.51M | 3.50M |
| Average Diluted Shares Outstanding | 4.17M | 4.04M | 3.51M | 3.51M | 3.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |